Rapid Rx Quiz: COVID-19 Treatment Updates

Mary L. Windle, PharmD


August 22, 2023

Adverse effects reported for ritonavir-boosted nirmatrelvir (Paxlovid) include dysgeusia as well as diarrhea, hypertension, and myalgia. Other patient experiences with Paxlovid include immune system disorders (eg, hypersensitivity reactions), gastrointestinal disorders (eg, abdominal pain, nausea), and administrative site conditions (eg, malaise).

Learn more about adverse effects of ritonavir-boosted nirmatrelvir (Paxlovid).

This Rapid Review Quiz was excerpted and adapted from the Medscape articles: Which Treatments Improve Long-Term Outcomes of Critical COVID Illness?, Interleukin Inhibitors, Nirmatrelvir/Ritonavir, COVID-19 Monoclonal Antibody Treatments No Longer Effective, Remdesivir, and Coronavirus Disease 2019 (COVID-19) Medication.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.